Compumedics Limited (ASX:CMP)

Australia · Delayed Price · Currency is AUD

0.2250

-0.0100 (-4.26%)

Aug 7, 2026, 1:27 PM AEST

-30.77% (1Y)

Market Cap	44.95M -28.0%
Revenue (ttm)	58.49M +23.5%
Net Income	113.00K
EPS	0.00
Shares Out	199.76M
PE Ratio	397.76
Forward PE	15.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,598
Open	0.2250
Previous Close	0.2350
Day's Range	0.2250 - 0.2250
52-Week Range	0.2150 - 0.4500
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1987

Employees 175

Stock Exchange Australian Securities Exchange

Ticker Symbol CMP

Full Company Profile

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.

Financial Statements